$3.5 million funds study aimed at applying precision medicine to rare tumor disorder

David Gutmann, MD, PhD, speaks with patient Sarah Bess and Stephanie Morris, MD, at the Neurofibromatosis Center at Washington University School of Medicine in St. Louis. Gutmann has received a grant to study the roots of the diversity of symptoms experienced by people with the genetic disorder. (Photo: Robert Boston/School of Medicine)
View Content

An international leader in neurofibromatosis research has received a $3.5 million grant to study why people with the same genetic mutation – in this case, a mutation that causes the genetic disorder known as neurofibromatosis type 1 (NF1) – develop markedly different signs and symptoms.